Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Medtronic
Express Scripts
McKinsey
Harvard Business School

Last Updated: September 27, 2022

Drugs with Dosage: SUPPOSITORY


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drugs with Dosage: SUPPOSITORY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Astrazeneca XYLOCAINE lidocaine SUPPOSITORY;RECTAL 013077-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;RECTAL
Bristol Myers Squibb STILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004056-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;VAGINAL
Bristol Myers Squibb STILBESTROL diethylstilbestrol SUPPOSITORY;VAGINAL 004056-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;VAGINAL
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-001 Approved Prior to Jan 1, 1982 OTC No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;RECTAL
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 018060-002 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;RECTAL
Endo Pharms NUMORPHAN oxymorphone hydrochloride SUPPOSITORY;RECTAL 011738-004 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing SUPPOSITORY;RECTAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Colorcon
AstraZeneca
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.